Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | DRD5 | P21918 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | MCOLN3 | Q8TDD5 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9978566 | 1.00 | LMNA (0.35) | LMNAHTTMAPK1SMN1; SMN2HPGD | |
| SCHEMBL1259047 | 0.81 | KCNH2 (0.38) | LMNAHTTHPGDALDH1A1CYP3A4 | |
| SCHEMBL20919908 | 0.81 | KCNH2 (0.38) | LMNAHTTHPGDALDH1A1CYP3A4 | |
| SCHEMBL20195364 | 0.79 | KCNH2 (0.35) | HPGDTSHRALDH1A1GAACYP3A4 | |
| SCHEMBL8698034 | 0.72 | SIGMAR1 (0.31) | MEN1KMT2A | |
| SCHEMBL23368545 | 0.67 | TDP1 (0.38) | LMNAHTTMAPK1SMN1; SMN2TSHR | |
| SCHEMBL3779703 | 0.66 | RECQL (0.31) | — | |
| SCHEMBL10884878 | 0.65 | ALDH1A1 (0.45) | HTTSMN1; SMN2HPGDTSHRALDH1A1 | |
| SCHEMBL6677443 | 0.64 | LMNA (0.45) | LMNAHTTSMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL22643223 | 0.64 | HPGD (0.36) | LMNASMN1; SMN2HPGDALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2723754-B1 | MULTIVALENT [BETA]-1-2-LINKED MANNOSE OLIGOSACCHARIDES AS IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF | TURUN YLIOPISTO (FI) | 2017-03-22 | — | — | EP | disclosed |
| US-9221861-B2 | Multivalent [beta]-1-2-linked mannose oligosaccharides as immunostimulatory compounds and uses thereof | ABO AKADEMI UNIVERSITY (FI) | 2015-12-29 | — | — | US | disclosed |
| EP-2723754-A1 | MULTIVALENT [BETA]- 1 - 2 - LINKED MANNOSE OLIGOSACCHARIDES AS IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF | Turun Yliopisto (FI) | 2014-04-30 | — | — | EP | disclosed |
| US-20140105932-A1 | MULTIVALENT [BETA] - 1 - 2 - LINKED MANNOSE OLIGOSACCHARIDES AS IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF | ÅBO AKADEMI UNIVERSITY (FI) | 2014-04-17 | — | — | US | disclosed |
| WO-2012175813-A1 | MULTIVALENT [BETA] - 1 - 2 - LINKED MANNOSE OLIGOSACCHARIDES AS IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF | TURUN YLIOPISTO (FI) | 2012-12-27 | — | — | WO | disclosed |
| US-20090247732-A1 | Synthesis of glycopeptides with superior pharmacokinetic properties | OPTIMER PHARMACEUTICALS, INC. (US) | 2009-10-01 | — | — | US | disclosed |
| WO-2005044197-A2 | SYNTHESIS OF GLYCOPEPTIDES WITH SUPERIOR PHARMACOKINETIC PROPERTIES | OPTIMER PHARMACEUTICALS, INC. (US) | 2005-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140105932-A1 | MULTIVALENT [BETA] - 1 - 2 - LINKED MANNOSE OLIGOSACCHARIDES AS IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF | CD4, MAN2A1, MANBA | LMNA 4829/4885HTT 3795/4885MAPK1 1238/4885 |
| US-20090247732-A1 | Synthesis of glycopeptides with superior pharmacokinetic properties | VIP, MGAT3, UGGT1 | LMNA 3832/4885HTT 2626/4885MAPK1 4837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.